HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Adinazolam

HCID 37632
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
37115-32-5
Standard SMILES
CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
InChIKey
GJSLOMWRLALDCT-UHFFFAOYSA-N
Molecular formula
C19H18ClN5
Average molar mass
351.8 g/mol
Monoisotopic mass
351.1250733

Overview

Adinazolam is a triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. It has a role as an antidepressant, an anxiolytic drug, an anticonvulsant and a sedative.

Names & identifiers

Preferred name
Adinazolam
IUPAC
1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine
English name
ADINAZOLAM
Molecular formula
C19H18ClN5
Molecular weight
351.83

Names & synonyms

ADINAZOLAM37115-32-5AdinazolamumU-411238-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepineDTXSID40190611U-41,123KN08449444CHEBI:2514128-chloro-1-[(dimethylamino)methyl]-6-phenyl-4h-s-triazolo[4,3-a][1,4]benzodiazepine((12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaen-3-yl)methyl)dimethylamine({12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methyl)dimethylamine
Show more names
Adinazolam (CRM)Adinazolam solution8-Chloro-N,N-dimethyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-1-methanamine4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-1-methanamine, 8-chloro-N,N-dimethyl-6-phenyl-γ-Aminobutyric acid Receptor,sickness,antihistamine,GABA Receptor,inhibit,Adinazolam,U-41123,U 41123,Huntington,Gamma-aminobutyric acid Receptor,anti-motion,piperazine,U41123,Inhibitor
RefChem:553043DTXCID80113102N05BA07Adinazolamum [INN-Latin]Deracyn1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamineU 41123Adinazolam [USAN]

Properties

Computed structural propertiesFilling in

XLogP
1.6
Topological polar surface area
46.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
25
Formal charge
0
Complexity
490

Experimental & physicochemical properties

Drugs · 3 items

DEA NFLIS-Drug Category -> Benzodiazepines

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP4.4
Solubility6.72e-02 g/L
Physical DescriptionSolid

Physicochemical properties

Melting point
171 · 171-172.5° (US 4250094); mp 165-166° (DE 2201210)
Boiling point
527 · 527.0±60.0 °C(Predicted)
Density
1.31 · 1.31±0.1 g/cm3(Predicted)
storage temp.
-10 to · -10 to -25°C
pka
6.2 · pKa 6.2 (D2O/DClor D2O/NaOD ) (Uncertain);5.8±0.1(D2O/DClor D2O/NaOD ) (Uncertain)
form
Solid
color
White to off-white

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 2
ridadr
3249
Signal word
Danger
Symbol(GHS)
GHS02,GHS08
hazard_class
6.1(b)
Storage Class
3 - Flammable liquids
packing_group
III
Hazard statements
H225-H370
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Flam. Liq. 2
Precautionary statements
P210-P233-P240-P241-P242-P243-P260-P264-P270-P280-P303+P361+P353-P307+P311-P321-P370+P378-P403+P235-P405-P501

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 item

Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Mechanism of Action · 1 item

Adinazolam binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.

Biological Half-LifeLess than 3 hours.
Metabolism/Metabolites · 2 items

The drug primarily undergoes hepatic metabolism to form the main metabolite N-desmethyladinazolam, alpha-hydroxyalprazolam, and estazolam.

Adinazolam has known human metabolites that include N-demethyladinazolam.

MeSH Pharmacological Classification · 1 item

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Cellular LocationsMembrane

Related reactions

5 records
New reaction record
HRID 268532 reaction equation
HRID 268532As product
HRID 441386 reaction equation
HRID 441386As product
HRID 903029 reaction equation
HRID 903029As product
HRID 1679592 reaction equation
HRID 1679592As product
HRID 2161108 reaction equation
HRID 2161108As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
37115-32-5
PubChem CID
37632
DTXSID
DTXSID40190611
ChEMBL
CHEMBL328250
ChEBI
CHEBI:251412
UNII
KN08449444
Nikkaji
J19.718A
InChI
1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3
InChIKey
GJSLOMWRLALDCT-UHFFFAOYSA-N
SMILES
Clc1cc2c(cc1)[n]3c(nnc3CN(C)C)CN=C2c4ccccc4
FDA UNII
8449444 · KN08449444
ATC code
5 BA07 · N05BA07
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
2 · GHS02,GHS08
Signal word
Danger
Hazard statements
225 · H225-H370
Precautionary statements
210 · P210-P233-P240-P241-P242-P243-P260-P264-P270-P280-P303+P361+P353-P307+P311-P321-P370+P378-P403+P235-P405-P501
RIDADR
3249 · 3249
WGK Germany
2 · WGK 2
HazardClass
6.1 · 6.1(b)
PackingGroup
III
Storage Class
3 · 3 - Flammable liquids
Hazard Classifications
4 DermalAcute · Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Flam. Liq. 2

Applications

UsesAntidepressant; sedative-hypnotic.

Additional notes

DefinitionChEBI: A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position.